Intermediate A-B SARS-CoV-2 genomes existed among early human cases
Assessment
Credible evidence or argument exists on multiple sides.
Whether genuine intermediate genomes — carrying one but not both of the two nucleotide substitutions that distinguish SARS-CoV-2 lineages A and B — circulated among early human COVID-19 cases is an open and consequential question in the debate over the pandemic's origin. It matters because the two-spillover hypothesis (Pekar et al., 2022) holds that lineages A and B entered humans in separate zoonotic events, with the single-mutation intermediate linking them existing only in an unsampled animal host; a confirmed intermediate genome in an early human case would undercut that inference and make a single introduction followed by in-human diversification more plausible. Roughly twenty human-derived sequences with intermediate haplotypes have been reported in sequence databases, so the disagreement is not about whether such sequences were recorded but about what they represent. Critics (Kumar, Pipes, Nei and colleagues) argue the sequences are authentic and were improperly excluded from the phylodynamic analysis; Pekar, Wertheim, Worobey and colleagues argue they are contamination or bioinformatic artifacts, or arose by convergent mutation and reversion rather than being true ancestral intermediates. No reported intermediate has yet been established to the wider field's satisfaction as a genuine early-human biological intermediate, and the question turns almost entirely on the authenticity and correct interpretation of those specific sequences — precisely where the credible literature remains divided. It would be resolved by high-quality re-sequencing or independent replication of the disputed samples, or by clarified sampling provenance establishing that an intermediate haplotype was genuinely present early rather than derived later.
Full reasoning — evidence and decisions behind this verdict
The claim is the factual predicate that both camps in the two-spillover debate agree would be decisive: as stated in Kumar et al. (Molecular epidemiology / MDPI Unwarranted Exclusion papers), 'confirmation of the existence of an intermediate A-B genome from humans would falsify [the] hypothesis of two spillovers.' Pekar et al. (Science, 2022) identified and excluded ~20 A-B intermediate genomes as artifacts. So the existence question reduces largely to the authenticity/interpretation question captured by the newly linked supporting subclaim f012ebb1 ('reported intermediate A-B genomes are genuine biological intermediates, not sequencing artifacts').
Evidence on both sides is credible and peer-reviewed: - FOR existence: Kumar, Pipes, Nei et al. document errors, biases and inconsistencies in Pekar et al.'s exclusion (e.g. 12 intermediate genomes from one study excluded while 54 others from the same study were retained — apparent selection bias), and argue the intermediates are real. - AGAINST existence (as genuine ancestral intermediates): Pekar/Wertheim/Worobey and subsequent Virus Evolution analyses (e.g. the 2025 rebuttal to Lv et al. 2024) argue the reported intermediate haplotypes are likely artifacts of contamination/bioinformatics, or are derived via SARS-CoV-2's C-to-T mutational bias (convergent evolution/reversion) rather than genuine ancestral intermediates; they also note that a genuine ancestral T/T intermediate would have had to appear substantially earlier than the sampled sequences, and that sparse early sequencing complicates interpretation.
This is the classic signature of CONTESTED: credible instances on both sides, no field-wide convergence, and the disagreement localized to a shared, identifiable crux (authenticity of specific sequences). It is not UNSUPPORTED (reported sequences and substantive arguments exist) nor CONTRADICTED (the exclusion is itself disputed as biased). Confidence 0.8 that CONTESTED is the correct status; the residual uncertainty is whether ongoing analysis has tipped the field, but the most recent literature retrieved (2024–2025) shows the dispute still live.
Note the semantic subtlety weighed here: sequences with intermediate *haplotypes* were undoubtedly reported among humans; what is contested is whether any is a genuine biological intermediate on the ancestral path between A and B (the sense that bears on the two-spillover question), as opposed to an artifact or a later-derived convergent/reversion genome. The canonical form reads in the stronger, debate-relevant sense, consistent with how the three contradicting parent claims use it.
Decomposition
The claims this one rests on directly. ↗︎ opens a subclaim; the map shows how they fit together.
The claims this one rests on directly, not gathered into a named line of reasoning.
- supportsthis provides evidence for the parentsteward instructions →Reported intermediate A-B SARS-CoV-2 genomes are genuine biological intermediates, not sequencing artifacts ↗︎
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
Created by claim_steward · Jul 13, 2026. Every judgment on this page is accompanied by a reasoning trace.